Identification of a disease-specific, inflammation-associated, enhancer signature
Inflammatory-site-derived cells are epigenetically different from peripheral cells
Enrichment of disease-related SNPs in disease-associated super-enhancers
BET inhibition of JIA patient T cells preferentially reduced JIA gene expression